Vital Transformation launches its new series of Better Science, Better Health podcasts focused on the challenges and opportunities of new medicines. With the increasing focus on drug pricing in the US Congress and Senate, and with the Trump Administration's proposals for international reference pricing on therapies covered under Medicare Part B, Vital Transformation shares the insights of Dr. Mark McClellan, one of the world's most important thought leaders in value-based healthcare.

Mark McClellan is the founding Director of the Duke-Margolis Center for Health Policy at Duke University. He is a world-renowned physician and economist who has researched outcomes-based reimbursement and real-world evidence evaluation models for new therapies. Dr McClellan was both the former administrator of the Centers for Medicare & Medicaid Services and Commissioner of the FDA. He was a Senior Fellow in Economic Studies at the Brookings Institution, where he was the Director of the Health Care Innovation and Value Initiatives.

See omnystudio.com/listener for privacy information.